Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimas Echeverria

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Brain Communications|December 2, 2022
Mutant huntingtin messenger RNA forms neuronal nuclear clusters in rodent and human brainsSocheata Ly, Marie-Cécile Didiot, Chantal M Ferguson, et al.
Nucleic Acid Therapeutics|October 13, 2017
Pharmacokinetic Profiling of Conjugated Therapeutic Oligonucleotides: A High-Throughput Method Based Upon Serial Blood Microsampling Coupled to Peptide Nucleic Acid Hybridization AssayBruno M D C Godinho, James W Gilbert, Reka A Haraszti, et al.
Nature Communications|July 8, 2018
Heavily and fully modified RNAs guide efficient SpyCas9-mediated genome editingAamir Mir, Julia F Alterman, Matthew R Hassler, et al.
Biorxiv : the Preprint Server for Biology|May 22, 2024
mRNA nuclear clustering leads to a difference in mutant huntingtin mRNA and protein silencing by siRNAs <i>in vivo</i>Sarah Allen, Daniel O'Reilly, Rachael Miller, et al.
Nucleic Acid Therapeutics|July 18, 2024
mRNA Nuclear Clustering Leads to a Difference in Mutant Huntingtin mRNA and Protein Silencing by siRNAs <i>In Vivo</i>Sarah Allen, Daniel O'Reilly, Rachael Miller, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 26, 2018
Optimized Cholesterol-siRNA Chemistry Improves Productive Loading onto Extracellular VesiclesReka Agnes Haraszti, Rachael Miller, Marie-Cecile Didiot, et al.
Bioconjugate Chemistry|May 3, 2017
Synthesis and Evaluation of Parenchymal Retention and Efficacy of a Metabolically Stable O-Phosphocholine-N-docosahexaenoyl-l-serine siRNA Conjugate in Mouse BrainMehran Nikan, Maire F Osborn, Andrew H Coles, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2023
Dual targeting of hepatocyte DGAT2 and stellate cell FASN alleviates nonalcoholic steatohepatitis in miceBatuhan Yenilmez, Shauna Harney, Chloe DiMarzio, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 14, 2025
Optimized chemical structure extends silencing duration of therapeutic siRNAs in dividing cancer and immune cellsAnastasia Kremer, Tatyana Ryaykenen, Xavier Segarra-Visent, et al.
Molecular Therapy. Nucleic Acids|December 13, 2023
Dendritic amphiphilic siRNA: Selective albumin binding, <i>in vivo</i> efficacy, and low toxicityHassan H Fakih, Qi Tang, Ashley Summers, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Brain Communications|December 2, 2022
Mutant huntingtin messenger RNA forms neuronal nuclear clusters in rodent and human brainsSocheata Ly, Marie-Cécile Didiot, Chantal M Ferguson, et al.
Nucleic Acid Therapeutics|October 13, 2017
Pharmacokinetic Profiling of Conjugated Therapeutic Oligonucleotides: A High-Throughput Method Based Upon Serial Blood Microsampling Coupled to Peptide Nucleic Acid Hybridization AssayBruno M D C Godinho, James W Gilbert, Reka A Haraszti, et al.
Nature Communications|July 8, 2018
Heavily and fully modified RNAs guide efficient SpyCas9-mediated genome editingAamir Mir, Julia F Alterman, Matthew R Hassler, et al.
Biorxiv : the Preprint Server for Biology|May 22, 2024
mRNA nuclear clustering leads to a difference in mutant huntingtin mRNA and protein silencing by siRNAs <i>in vivo</i>Sarah Allen, Daniel O'Reilly, Rachael Miller, et al.
Nucleic Acid Therapeutics|July 18, 2024
mRNA Nuclear Clustering Leads to a Difference in Mutant Huntingtin mRNA and Protein Silencing by siRNAs <i>In Vivo</i>Sarah Allen, Daniel O'Reilly, Rachael Miller, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 26, 2018
Optimized Cholesterol-siRNA Chemistry Improves Productive Loading onto Extracellular VesiclesReka Agnes Haraszti, Rachael Miller, Marie-Cecile Didiot, et al.
Bioconjugate Chemistry|May 3, 2017
Synthesis and Evaluation of Parenchymal Retention and Efficacy of a Metabolically Stable O-Phosphocholine-N-docosahexaenoyl-l-serine siRNA Conjugate in Mouse BrainMehran Nikan, Maire F Osborn, Andrew H Coles, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2023
Dual targeting of hepatocyte DGAT2 and stellate cell FASN alleviates nonalcoholic steatohepatitis in miceBatuhan Yenilmez, Shauna Harney, Chloe DiMarzio, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 14, 2025
Optimized chemical structure extends silencing duration of therapeutic siRNAs in dividing cancer and immune cellsAnastasia Kremer, Tatyana Ryaykenen, Xavier Segarra-Visent, et al.
Molecular Therapy. Nucleic Acids|December 13, 2023
Dendritic amphiphilic siRNA: Selective albumin binding, <i>in vivo</i> efficacy, and low toxicityHassan H Fakih, Qi Tang, Ashley Summers, et al.
Pageof 9